{"id":10404,"date":"2026-07-25T20:11:33","date_gmt":"2026-07-25T17:11:33","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=10404"},"modified":"2026-07-25T20:11:33","modified_gmt":"2026-07-25T17:11:33","slug":"resistant-hypertension-dont-forget-cortisol","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/resistant-hypertension-dont-forget-cortisol\/","title":{"rendered":"Resistant Hypertension? Don\u2019t Forget Cortisol"},"content":{"rendered":"<p><span>Resistant Hypertension? Don\u2019t Forget Cortisol<\/span><\/p>\n<p><span>* Resistant hypertension (HTN) affects approximately 8.5%\u201320% of patients with hypertension.<\/span><br \/>\n<span>* Hypercortisolism is an often-overlooked secondary cause of resistant HTN.<\/span><br \/>\n<span>* In the multicenter MOMENTUM study, 27.3% of U.S. patients with resistant HTN had hypercortisolism.<\/span><br \/>\n<span>* Before adding another antihypertensive drug, clinicians should consider screening for excess cortisol as a potentially treatable cause.<\/span><br \/>\n<span>* In resistant hypertension, however, clinicians should consider screening for hypercortisolism using a first-line test (overnight 1-mg dexamethasone suppression test, late-night salivary cortisol, or 24-hour urinary free cortisol).<\/span><\/p>\n<p><span>Source: Medscape. July 21, 2026. Based on the MOMENTUM study.<\/span><\/p>\n<p><a href=\"https:\/\/www.medscape.com\/viewarticle\/dont-overlook-cortisol-resistant-hypertension-2026a1000nza\" target=\"_blank\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.medscape.com\/viewarticle\/dont-overlook-cortisol-resistant-hypertension-2026a1000nza&amp;source=gmail&amp;ust=1785085860020000&amp;usg=AOvVaw36qRWw44Q1NT5U7qhp4VSC\" rel=\"noopener\">https:\/\/www.medscape.com\/<wbr \/>viewarticle\/dont-overlook-<wbr \/>cortisol-resistant-<wbr \/>hypertension-2026a1000nza<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Resistant Hypertension? Don\u2019t Forget Cortisol * Resistant hypertension (HTN) affects approximately 8.5%\u201320% of patients with hypertension. * Hypercortisolism is an often-overlooked secondary cause of resistant HTN. * In the multicenter MOMENTUM study, 27.3% of U.S. patients with resistant HTN had hypercortisolism. * Before adding another antihypertensive drug, clinicians should consider screening for excess cortisol as [&hellip;]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-10404","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10404","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=10404"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10404\/revisions"}],"predecessor-version":[{"id":10405,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/10404\/revisions\/10405"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=10404"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=10404"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=10404"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}